Fair Value Calculator Fair Value Calculator
EN DE

KEMISTAR (KEMISTAR) Fair Value & Analysis

IN · Market cap ₹534M

K KEMISTAR KEMISTAR · BSE
Price₹49.67
Fair Value₹11.85
Upside-76.1%
Quality43/100
Watch KEMISTAR for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹8.79 – ₹11.85

Fair value as of: Jul 5, 2026

From 16 valuation models · updated today

Share price −14.8% over the past month.

Price vs Fair Value (12 months)

₹103.35 ₹47.16 Fair Value ₹11.85 Jul 2025 Jul 2026

12‑month range ₹47.16 – ₹103.35 · fair‑value band ₹8.79 – ₹11.85 · the ₹49.67 price screens above the ₹11.85 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

KEMISTAR (KEMISTAR) currently trades at ₹49.67, while our model-based Fair Value estimate is ₹11.85 — implying the stock looks roughly 76.1% overvalued today. We read business quality at 43/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, KEMISTAR generated revenue of ₹270M at a net margin of 2.1%. Revenue grew 43.1% year over year. It earns a return on equity of 3.0%. Net debt stands at ₹87.8M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹8.79 (bear case) to ₹11.85 (bull case); at ₹49.67, the current price sits above that range. The share trades about 54% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹270M
Revenue growth (YoY) +43.1%
Net margin 2.1%
Return on equity 3.0%
Free cash flow −₹3.3M FY2025
P/E ratio 95.5
More key figures
Operating margin 4.3%
EPS (TTM) ₹0.5200
EPS growth (YoY) +48.6%
Net debt ₹87.8M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

KEMISTAR reported revenue of ₹270M in FY2025 versus ₹209M in FY2021, a compound +6.5%/yr. Reported net income was ₹5.6M in FY2025, compounding −9.7%/yr from FY2021.

Revenue +6.5%/yr
FY21 ₹209M
FY22 ₹182M
FY23 ₹111M
FY24 ₹181M
FY25 ₹270M
Net income −9.7%/yr
FY21 ₹8.4M
FY22 ₹8.4M
FY23 ₹5.3M
FY24 ₹6.0M
FY25 ₹5.6M

Is KEMISTAR fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "KEMISTAR Fair Value". https://www.fairvalue-calculator.com/stock/KEMISTAR

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is KEMISTAR (KEMISTAR) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹11.85 versus a price of ₹49.67 — about −76% (overvalued). Model-based estimate, not financial advice.
What is the fair value of KEMISTAR?
Our model-based fair value for KEMISTAR is ₹11.85 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹49.67.
What is the quality score of KEMISTAR?
KEMISTAR has a Quality Score of 43/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of KEMISTAR (KEMISTAR)?
KEMISTAR reported trailing-twelve-month revenue of about ₹270M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of KEMISTAR?
The net profit margin of KEMISTAR is about 2.1%, meaning it keeps roughly 2.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.